Related Experiment Video
Updated: Jan 30, 2026

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
Association between probiotic supplementation and asthma incidence in infants: a meta-analysis of randomized
Xiaochen Wei1, Ping Jiang2, Jiangbo Liu2
1Department of Pharmacy, Tianjin First Central Hospital, Tianjin, People's Republic of China.
Insights
Probiotics do not significantly reduce asthma or wheeze risk in infants overall. However, they may lower wheeze incidence in infants with atopy disease.
Area of Science:
- Pediatric Allergy and Immunology
- Microbiome Research
- Public Health
Background:
- Infant asthma presents significant social and economic challenges.
- Probiotics are explored for asthma prevention, but trial results are inconsistent.
Purpose of the Study:
- To evaluate the efficacy of probiotic supplementation in preventing asthma and wheeze in infants through a meta-analysis of randomized controlled trials (RCTs).
Main Methods:
- Systematic literature search of PubMed, Cochrane Library, and EMBASE databases up to August 2018.
- Inclusion of 19 RCTs with 5157 children comparing probiotics to placebo for infant asthma/wheeze.
- Meta-analysis using Mantel-Haenszel method to calculate risk ratios (RR) and 95% confidence intervals (CI).
Main Results:
- Overall, probiotics showed no significant association with reduced asthma risk (RR, 0.94 [95% CI, 0.82-1.09]) or wheeze (RR, 0.97 [95% CI, 0.88-1.06]).
- A significant reduction in wheeze incidence was observed in infants with atopy disease (RR, 0.61 [95% CI, 0.42-0.90]).
- No significant effects were found in other subgroup analyses based on intervention details or probiotic type.
Conclusions:
- Probiotic supplementation does not appear to lower the overall risk of asthma in infants compared to placebo.
- Current evidence does not support recommending probiotics for infant asthma prevention, except potentially for reducing wheeze in infants with atopy.
Abstract:
Objective: The increased social and economic burdens for asthma in infants make the prevention of asthma a major public health goal. Probiotics may reduce the risk of asthma in infants. However, randomized controlled trials (RCTs) have shown mixed efficacy outcomes. We performed a meta-analysis of RCTs to investigate whether probiotics are associated with a lower asthma incidence in infants. Methods: The PubMed, Cochrane library, and EMBASE databases were systematically searched from the inception dates to August 2018. RCTs comparing the effects of probiotic supplements with a placebo for asthma or wheeze incidence in infants were included. A meta-analysis was performed to calculate risk ratio (RR) and 95% confidence interval (CI) using the Mantel-Haenszel statistical method. Results: A total of 19 randomized trials involving 5157 children fulfilled the inclusion criteria. There was no significant association of probiotics with risk of asthma (RR, 0.94 [95% CI, 0.82-1.09]) or wheeze (RR, 0.97 [95% CI, 0.88-1.06]) compared with placebo. Subgroup analysis by asthma risk showed that probiotics significantly reduced wheeze incidence among infants with atopy disease (RR, 0.61 [95% CI, 0.42-0.90]), but no significant associations were found in the other subgroup analyses by participants receiving the intervention, timing of intervention, prevention regimen, probiotic organism, duration of intervention, and duration of follow-up. Conclusions: The use of probiotic supplementation compared with placebo was not associated with a lower risk of asthma in infants. These findings do not support recommendation to use probiotics in the prevention of asthma in infants.
Related Concept Videos
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Statistical Software for Data Analysis and Clinical Trials
Asthma-I: Introduction
Clinical Trials: Overview
Trial and Error and Algorithm
Asthma-III: Symptoms and Complications
Classification of Asthma

